BIIB Earnings
Biogen next reports earnings on October 29, 2026. Track record: 4/4 beats.
Next Earnings In
Thursday, October 29, 2026
Current Price
$218.50
EPS Estimate
Earnings Per Share
$2.04
-57.7% YoY
Trailing EPS
Last 12 months earnings
$5.55
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
13.2
Margin: 8.3%
Analyst Rating
31 analysts
Analyst Sentiment
Buy31 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-06-30 | $2.03 | $3.60 | +77.4% | Beat |
| 2026-03-31 | $2.95 | $3.57 | +20.9% | Beat |
| 2025-12-31 | $1.62 | $1.99 | +23.2% | Beat |
| 2025-09-30 | $3.88 | $4.81 | +23.9% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $2.04 | $2.6B | -57.7% |
| Next Qtr(+1q) | $3.27 | $2.6B | +64.2% |
| Current Year(0y) | $12.41 | $10.4B | -18.8% |
| Next Year(+1y) | $16.54 | $10.7B | +33.2% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$2.04
Revenue Estimate
$2.6B
Annual EPS Est.
$12.41
-18.8% YoY
BIIB Earnings FAQ
When is BIIB's next earnings date?
Biogen (BIIB) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $2.04.
Does BIIB usually beat earnings estimates?
Biogen has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is BIIB's trailing EPS?
Biogen's trailing twelve-month EPS is $5.55. This is calculated from the last four quarters of reported earnings.
What do analysts think about BIIB?
31 Wall Street analysts cover Biogen. The consensus rating is "Buy" with an average price target of $236.22, implying 8.1% upside from the current price.